Ignite Creation Date:
2024-05-05 @ 9:16 PM
Last Modification Date:
2024-10-26 @ 10:02 AM
Study NCT ID:
NCT00855998
Status:
UNKNOWN
Last Update Posted:
2010-06-03
First Post:
2009-02-22
Brief Title:
Thymidine Kinase 1 in Risk Assessment for Hereditary Breast Ovarian Cancer
Sponsor:
Organization:
Hadassah Medical Organization
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Serum
Enrollment Count:
300
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Family-Based |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 7490 |
Who Masked List: